Skip to main content
Search
Main content
Brain cell imaging

Building an atlas of the Alzheimer's brain

The Multi-‘Omics Atlas Project (MAP) from the UK DRI at Imperial

multiomics atlas project logo

Key details

UK DRI at Imperial
Dr Johanna Jackson (Senior Scientific Project Manager & UK DRI Emerging Leader)

Alzheimer’s accounts for two thirds of all dementia cases, and yet our understanding of the underlying causes is still very limited. Uncovering the biological mechanisms behind the disease is essential in finding ways to treat it. The Multi-‘omics Atlas Project (MAP), which ran from 2020 to 2023, was set up to create an ‘atlas’ of the brain at different stages of Alzheimer’s, to improve understanding of the processes that lead to people developing the disease.

The research team studied the brains of 14 people who had Alzheimer’s and 14 controls. The team used an unprecedented range of advanced techniques to examine tissue from multiple brain regions, aiming to gain an understanding of the genetics, and the role of proteins and other factors in key characteristics of Alzheimer’s disease.

The main aim of the project was to develop a resource pool for the research community. Data from the project will soon be made publicly available on the MAP website.

£2m

invested into the project

8

different brain regions examined

14

Alzheimer's brains and 14 control brains studied

Collaborators

UK DRI labs

Jackson Lab

Investigating synaptic vulnerability in Alzheimer's

Learn more Jackson Lab

Matthews Lab

Exploring neuronal vulnerability and genetic risk variants in Alzheimer’s progression

Learn more Matthews Lab

Key publications

Nat Commun
Published

Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology.

Authors
Zoeb Jiwaji, Sachin S Tiwari, Rolando X Avilés-Reyes, Monique Hooley, David Hampton, Megan Torvell, Delinda A Johnson, Jamie McQueen, Paul Baxter, Kayalvizhi Sabari-Sankar, Jing Qiu, Xin He, Jill Fowler, James Febery, Jenna Gregory, Jamie Rose, Jane Tulloch, Jamie Loan, David Story, Karina McDade, Amy M Smith, Peta Greer, Matthew Ball, Peter C Kind, Paul M Matthews, Colin Smith, Owen Dando, Tara L Spires-Jones, Jeffrey A Johnson, Siddharthan Chandran, Giles E Hardingham
Reactive astrocytes acquire neuroprotective as well as deleterious signatures in response to Tau and Aß pathology.